kronisk nyresvigt (CRF), som enten var eller ikke var i dialysebehandling, blev der fastlagt farmakokinetiske profiler for prøverperioder op til 1 uge (168 timer) efter en enkelt subkutan eller te
who were either receiving or not receiving dialysis determined pharmacokinetic profiles for sampling periods up to 1 week (168 hours) after a single subcutaneous or intravenous dose.